Senti Biosciences is trading 10.53% down at $0.39 after falling from its August 20, 2026 close of $0.44; available coverage attributes the decline to sector-driven biotech weakness, though broader market indices are higher and supplied sector context shows biotechnology advancing.
- No new company-specific announcement was identified on August 21, 2026.
- The sector-based explanation is therefore less definitive.